Investment Objective
Mean-reversion sector exposure
Target sectors in deep drawdown through a contrarian, mean-reversion ETF approach. Designed for patient investors who can tolerate extended periods of underperformance.
Featured Strategy
Focused on sectors or indices that are in a deep drawdown state, seeking mean-reversion opportunities.
Portfolio Spotlight
Focused on sectors or indices that are in a deep drawdown state, seeking mean-reversion opportunities.
Explainer Video
Introducing Mirae Asset Contra Fund
Performance
Compare growth against a benchmark across timelines and see what a hypothetical investment would be worth today.
Overview
Key metrics, suitability, and strategy highlights to help you evaluate whether this model portfolio fits your goals.
Investment Objective
Target sectors in deep drawdown through a contrarian, mean-reversion ETF approach. Designed for patient investors who can tolerate extended periods of underperformance.
Investors with higher risk tolerance who believe deeply discounted sectors may recover over a longer horizon and can tolerate extended underperformance.
Contrarian strategies can remain out of favour for long stretches. Sector recovery timing is uncertain and losses may deepen before a turnaround.
Holdings
Review the ETF mix and segment allocation that defines this model portfolio.
FAQs
Common questions about Mirae Asset Contra Fund and what to expect when you invest.
Mirae Asset Contra Fund is a contrarian sector ETF model portfolio focused on areas that have experienced deep drawdowns, seeking mean-reversion opportunities over a longer horizon.
The strategy includes sector sleeves such as PSU banks, IT, pharma, and midcap equity, alongside core large-cap and liquid ETF exposure for balance.
Contrarian positioning can remain out of favour for long periods. Discounted sectors may stay weak or weaken further before any recovery materializes.
It is suited to very high risk tolerance investors who believe selected sectors may recover over time and can withstand extended underperformance.
Sector weights and drawdown conditions are reviewed monthly. Rebalancing follows predefined rules rather than discretionary timing calls.
The minimum investment for this portfolio is ₹20,000.
Collateral
Download portfolio documents and review the scheduled rebalance checkpoints for this strategy.
Q1 Review — January 2026
Quarterly allocation check against model targets and drift thresholds.
Q2 Review — April 2026
Mid-year review of macro signals, risk metrics, and sleeve performance.
Q3 Review — July 2026
Thematic and factor sleeve review with updated market regime assessment.
Q4 Review — October 2026
Year-end reset to target weights and annual strategy documentation update.